Carlyle Genesis UK LLC's Net Worth
$333 Million
Who is Carlyle Genesis UK LLC?
Carlyle Genesis UK LLC has an estimated net worth of $333 Million. This is based on reported shares across multiple companies, which include SOLENO THERAPEUTICS INC, Vera Therapeutics, Inc., Jasper Therapeutics, Inc., and eFFECTOR Therapeutics, Inc..
SEC CIK
Carlyle Genesis UK LLC's CIK is 0001941860
Past Insider Trading and Trends
2023 was Carlyle Genesis UK LLC's most active year for acquiring shares with 5 total transactions. Carlyle Genesis UK LLC's most active month to acquire stocks was the month of April. 2022 was Carlyle Genesis UK LLC's most active year for disposing of shares, totalling 4 transactions. Carlyle Genesis UK LLC's most active month to dispose stocks was the month of July. 2023 saw Carlyle Genesis UK LLC paying a total of $7,881,097.28 for 7,095,445 shares, this is the most they've acquired in one year. In 2022 Carlyle Genesis UK LLC cashed out on 19,850 shares for a total of $201,026.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $46.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.46% | 329.93K |
$1.75 | $577,377.50 | 1.53M |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$15.63 | -$91,851.11 | 2.96M |
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jasper Therapeutics, Inc. (JSPR) Snapshot price: $17.645
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.68% | 190K |
$12.95 | $2,460,500.00 | 1.07M |
Feb 8
| |||
Form 4
| +55.67% | 3.13M |
$1.50 | $4,699,999.50 | 8.76M |
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $9.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||